Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1996-03-27
1998-10-06
Ulm, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C07K 14705
Patent
active
058177604
ABSTRACT:
The invention concerns recombinant human adenosine receptors A1, A2a, A2b and A3 which have been prepared by cDNA cloning and polymerase chain reaction techniques. The invention also concerns expression systems for these receptors and an assay using the expression systems. The recombinant adenosine receptors comprising the invention can be utililized in an assay to identify and evaluate entities that bind to or enhance binding to adenosine receptors.
REFERENCES:
C. Maenhaut, et al., Biochem. Biophys. Res. Comm., (1990) 173:1169-1178.
L.C. Mahan, et al., (1991) Mol. Pharm. 40:1-7.
S.M. Reppert, et al., (1991) Mol. Endocrin. 5:1037-1048.
Zhou, O.-Y. et al., "Molecular Cloning . . . of . . . A3 Adenosine receptor," Proc. Nat. Acad. Sci. 89, 7432 (1992).
Pierce, K.D. et al., "Molecular Cloning and Expression . . . " Biochemical and Biophysical Research Communications, vol. 187, No. 1, 86-93 (1992).
Furlong, T.J. et al., "Molecular characterization of a human . . . " Molecular Brain Research, 15, 62-66 (1992).
Olah, M.E. et al., ". . . Characterization of . . . Bovine A. Adnosine Receptor," J. Biol. Chem. 267, 10764 (1992) Issue of May 25).
Chern, Y. et al., ". . . Cloning of . . . Adenosine Receptor Gene From Rat Brain," BBRC 185, 304 (1992).
Tiffany, H.L. et al., "Human Adenosine receptor (A2) gene . . . " Gen Bank, Accession M97370 (Jul. 25, 1992) (3 pages).
Fink, J.S. et al., ". . . Cloning of the rat A2 adenosine receptor . . ., " Mol. Brain Res. 14, 186 (1992).
Nakata, H., et al., J. Biol. Chemistry, vol. 264, pp. 16545-16551 (1989).
Jackson, Pharm. Ther., vol. 50, pp. 425-442 (1991).
J.H. Stehle, et al: Molecular Cloning and Expression of the cDNA for a Novel A.sub.2 Adenosine Receptor Subtype, Molecular Endocrinology, No. 3, vol. 6, pp. 384-393 (Mar., 1992).
R.F. Bruns, et al., (1983) Proc. Natl. Acad. Sci. USA 80:2077-2080.
R.F. Bruns, et al., (1986) Mol. Pharmacol. 29:331-346.
K.A. Jacobson, et al., (1989) J. Med. Chem 32:1043-1051.
M.F. Jarvis, et al., (1989) J. Pharma. Esp. Therap. 251:888-893.
F. Libert, et al., (1989) Science 244:569-572.
F. Libert, et al., (1991) EMBO J. 10:1677-1682.
A.L. Tucker, et al (1992) FEBS vol. 297, 107-111.
Nakata, J. Biol. Chem. 265(2):671-677, 1990.
Nakata, Euro. J. Biochem. 206:171-177, 1992.
Jacobson Marlene A.
Johnson Robert G.
Luneau Christopher J.
Salvatore Christopher A.
Merck & Co. , Inc.
Parr Richard S.
Ulm John
Winokur Melvin
LandOfFree
Human A3 adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human A3 adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human A3 adenosine receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-78361